Jennifer L. Reichek, MD, MSW

Attending Physician, Hematology/Oncology; Director, STAR Program (Survivors Taking Action & Responsibility)

Assistant Professor of Pediatrics, Northwestern University Feinberg School of Medicine

Appointments & Referrals

1.800.543.7362 (1.800.KIDS DOC)

About Me

Clinical Interests: Solid tumors, adolescent oncology, long term effects of pediatric cancer therapy, psychosocial impact of having cancer as a child/adolescent

Specialties, Programs & Conditions

Specialties:

Pediatric Hematology & Oncology >

Education & Training

Education: MCP Hahnemann University College of Medicine, Philadelphia, PA, 2002

Postgraduate Training: Fellowship in hematology/oncology, Children's Hospital of Philadelphia, 2005-2008; Residency in pediatrics, Children's Hospital of Philadelphia, 2002-2005

Board Certifications: General Pediatrics, Pediatric Hematology-Oncology

Professional Organizations: American Association for Cancer Research; American Society of Clinical Oncology; American Society of Pediatric Hematology Oncology; Children's Oncology Group; Critical Mass Young Adult Alliance

Publications

Most recent publications

Late Effects in Pediatric High-risk Neuroblastoma Survivors After Intensive Induction Chemotherapy Followed by Myeloablative Consolidation Chemotherapy and Triple Autologous Stem Cell Transplants J Pediatr Hematol Oncol 40 (1): 31-35
Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital Support Care Cancer 25 (5): 1579-1586
Treatment of neuroblastoma in congenital central hypoventilation syndrome with a PHOX2B polyalanine repeat expansion mutation: New twist on a neurocristopathy syndrome Pediatr Blood Cancer 62 (11): 2007-10
Irinotecan and temozolomide for treatment of neuroblastoma in a patient with renal failure on hemodialysis Pediatr Blood Cancer 61 (5): 949-50
What is new in rhabdomyosarcoma management in children? Paediatr Drugs 14 (6): 389-400
Gemcitabine With or Without Docetaxel and Resection for Recurrent Osteosarcoma: The Experience at Children's Memorial Hospital J Pediatr Hematol Oncol 34 (2): e63-5